336 related articles for article (PubMed ID: 17672066)
1. [Pharmacotherapy of rheumatoid arthritis in the era of genetically engineered biological preparations].
Nasonov EL
Ter Arkh; 2007; 79(5):5-8. PubMed ID: 17672066
[No Abstract] [Full Text] [Related]
2. [TNF-alpha antagonist in rheumatoid arthritis. Joint destruction can be controlled].
MMW Fortschr Med; 2003 Oct; 145(41):46. PubMed ID: 14655484
[No Abstract] [Full Text] [Related]
3. Should we be using intraarticular tumor necrosis factor blockade in inflammatory monoarthritis?
Fisher BA; Keat A
J Rheumatol; 2006 Oct; 33(10):1934-5. PubMed ID: 17014012
[No Abstract] [Full Text] [Related]
4. Tumor necrosis factor inhibitors for rheumatoid arthritis.
Scott DL; Kingsley GH
N Engl J Med; 2006 Aug; 355(7):704-12. PubMed ID: 16914706
[No Abstract] [Full Text] [Related]
5. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
6. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
7. [Biological agents for therapy of rheumatoid arthritis--overview].
Takeuchi T
Nihon Rinsho; 2005 Jan; 63 Suppl 1():513-6. PubMed ID: 15799409
[No Abstract] [Full Text] [Related]
8. Rheumatoid arthritis.
Burchini G; Orsi C
N Engl J Med; 2004 Sep; 351(13):1360-1; author reply 1360-1. PubMed ID: 15385669
[No Abstract] [Full Text] [Related]
9. The 'alphabet' of rheumatoid arthritis treatment.
Capriotti T
Medsurg Nurs; 2004 Dec; 13(6):420-8. PubMed ID: 15714747
[No Abstract] [Full Text] [Related]
10. [The efficacy of the three available anti-tumour necrosis factor therapies in patients with rheumatoid arthritis. A meta-analytic literature review--secondary publication].
Christensen R; Kristensen LE; Geborek P; Danneskiold-Samsøe B; Saxne T; Bliddal H
Ugeskr Laeger; 2009 Jun; 171(26):2192-4. PubMed ID: 19678436
[TBL] [Abstract][Full Text] [Related]
11. New drugs for rheumatoid arthritis.
Olsen NJ; Stein CM
N Engl J Med; 2004 May; 350(21):2167-79. PubMed ID: 15152062
[No Abstract] [Full Text] [Related]
12. Anticytokine therapy--a new era in the treatment of rheumatoid arthritis?
O'Dell JR
N Engl J Med; 1999 Jan; 340(4):310-2. PubMed ID: 9920958
[No Abstract] [Full Text] [Related]
13. New drugs for rheumatoid arthritis.
Messori A; Santarlasci B; Vaiani M
N Engl J Med; 2004 Aug; 351(9):937-8. PubMed ID: 15329436
[No Abstract] [Full Text] [Related]
14. [New treatments for rheumatoid arthritis].
Girault V; Flipo RM
Soins; 2004 Sep; (688):37-8. PubMed ID: 15515847
[No Abstract] [Full Text] [Related]
15. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
16. Biologic therapy for rheumatoid arthritis.
Klippel JH
N Engl J Med; 2000 Nov; 343(22):1640-1. PubMed ID: 11096174
[No Abstract] [Full Text] [Related]
17. [TNF antagonists in therapy of rheumatoid arthritis].
Oberpichler-Schwenk H
Med Monatsschr Pharm; 1999 Nov; 22(11):334-9. PubMed ID: 10596266
[No Abstract] [Full Text] [Related]
18. Antibodies against mutated citrullinated vimentin fail to predict anti-TNFalpha treatment response in rheumatoid arthritis.
Dejaco C; Duftner C; Klotz W; Schirmer M; Herold M
Scand J Rheumatol; 2009; 38(1):66-7. PubMed ID: 18759163
[No Abstract] [Full Text] [Related]
19. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
20. Drug survival on TNF inhibitors: 2003-2004 data from Italian National Register (GISEA Register).
Iannone F; Ferraccioli G; Gremese E; Lapadula G;
Ann Rheum Dis; 2014 Jun; 73(6):e31. PubMed ID: 24368512
[No Abstract] [Full Text] [Related]
[Next] [New Search]